S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

NYSE:BCSFBain Capital Specialty Finance Stock Price, Forecast & News

$10.91
+0.18 (+1.68 %)
(As of 08/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$10.75
Now: $10.91
$10.96
50-Day Range
$9.48
MA: $10.50
$12.11
52-Week Range
$7.11
Now: $10.91
$20.35
Volume151,900 shs
Average Volume326,239 shs
Market Capitalization$704.37 million
P/E RatioN/A
Dividend Yield15.03%
Beta1.5
Bain Capital Specialty Finance, Inc. operates as a business development company (BDC) specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA between $10 million and $150 million.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 1.8Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.42 out of 5 stars


Industry, Sector and Symbol

Industry Holding & other investment offices
Sub-IndustryN/A
SectorFinance
CUSIPN/A
CIKN/A
Phone617-516-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$197.95 million
Cash Flow$1.61 per share
Book Value$15.81 per share

Profitability

Net Income$98.08 million

Miscellaneous

EmployeesN/A
Market Cap$704.37 million
Next Earnings Date11/4/2020 (Estimated)
OptionableNot Optionable
$10.91
+0.18 (+1.68 %)
(As of 08/13/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BCSF News and Ratings via Email

Sign-up to receive the latest news and ratings for BCSF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Bain Capital Specialty Finance (NYSE:BCSF) Frequently Asked Questions

How has Bain Capital Specialty Finance's stock been impacted by COVID-19 (Coronavirus)?

Bain Capital Specialty Finance's stock was trading at $16.84 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BCSF stock has decreased by 35.2% and is now trading at $10.91.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Bain Capital Specialty Finance?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bain Capital Specialty Finance in the last year. There are currently 1 sell rating, 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Bain Capital Specialty Finance
.

When is Bain Capital Specialty Finance's next earnings date?

Bain Capital Specialty Finance is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Bain Capital Specialty Finance
.

How were Bain Capital Specialty Finance's earnings last quarter?

Bain Capital Specialty Finance Inc (NYSE:BCSF) issued its quarterly earnings results on Wednesday, August, 5th. The company reported $0.37 earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of $0.37. The business had revenue of $47.87 million for the quarter, compared to analyst estimates of $54.71 million. Bain Capital Specialty Finance had a positive return on equity of 8.61% and a negative net margin of 20.85%.
View Bain Capital Specialty Finance's earnings history
.

How often does Bain Capital Specialty Finance pay dividends? What is the dividend yield for Bain Capital Specialty Finance?

Bain Capital Specialty Finance declared a quarterly dividend on Wednesday, August 5th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.34 per share on Friday, October 30th. This represents a $1.36 annualized dividend and a dividend yield of 12.47%. The ex-dividend date of this dividend is Tuesday, September 29th.
View Bain Capital Specialty Finance's dividend history
.

What price target have analysts set for BCSF?

8 Wall Street analysts have issued twelve-month price targets for Bain Capital Specialty Finance's stock. Their forecasts range from $7.50 to $19.50. On average, they anticipate Bain Capital Specialty Finance's share price to reach $12.14 in the next year. This suggests a possible upside of 11.3% from the stock's current price.
View analysts' price targets for Bain Capital Specialty Finance
.

Has Bain Capital Specialty Finance been receiving favorable news coverage?

News headlines about BCSF stock have been trending negative on Thursday, according to InfoTrie. The research firm scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Bain Capital Specialty Finance earned a coverage optimism score of -2.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future.
View the latest news about Bain Capital Specialty Finance
.

Are investors shorting Bain Capital Specialty Finance?

Bain Capital Specialty Finance saw a decrease in short interest in the month of June. As of June 30th, there was short interest totaling 337,500 shares, a decrease of 73.8% from the June 15th total of 1,290,000 shares. Based on an average daily volume of 343,800 shares, the days-to-cover ratio is currently 1.0 days.
View Bain Capital Specialty Finance's Short Interest
.

Who are some of Bain Capital Specialty Finance's key competitors?

What other stocks do shareholders of Bain Capital Specialty Finance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bain Capital Specialty Finance investors own include Verizon Communications (VZ), AbbVie (ABBV), Walt Disney (DIS), AT&T (T), Enterprise Products Partners (EPD), Bank of America (BAC), Energy Transfer LP Unit (ET), JPMorgan Chase & Co. (JPM), Pfizer (PFE) and Exxon Mobil (XOM).

Who are Bain Capital Specialty Finance's key executives?

Bain Capital Specialty Finance's management team includes the following people:
  • Mr. Michael Alexander Ewald, Pres, CEO & Director (Age 45)
  • Ms. Sally Fassler Dornaus CPA, CPA, Chief Financial Officer (Age 44)
  • Mr. Derek Kirby, Investor Contact
  • Mr. James Goldman, Chief Compliance Officer (Age 42)
  • Mr. James S. Athanasoulas, VP & Treasurer (Age 45)

When did Bain Capital Specialty Finance IPO?

(BCSF) raised $156 million in an initial public offering (IPO) on Thursday, November 15th 2018. The company issued 7,500,000 shares at $20.25-$21.25 per share. BofA Merrill Lynch, Goldman Sachs, Morgan Stanley, Citigroup, Credit Suisse, Keefe, Bruyette & Woods (A Stifel Company) and Wells Fargo Securities served as the underwriters for the IPO and Janney Montgomery Scott, JMP Securities and Academy Securities were co-managers.

What is Bain Capital Specialty Finance's stock symbol?

Bain Capital Specialty Finance trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCSF."

Who are Bain Capital Specialty Finance's major shareholders?

Bain Capital Specialty Finance's stock is owned by a number of retail and institutional investors. Top institutional investors include UBS Group AG (3.31%), Starr International Co. Inc. (1.43%), Sumitomo Mitsui Trust Holdings Inc. (0.88%), C.V. Starr & Co. Inc. Trust (0.74%), Beaumont Financial Partners LLC (0.52%) and Raymond James Financial Services Advisors Inc. (0.20%). Company insiders that own Bain Capital Specialty Finance stock include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle and Thomas A Hough.
View institutional ownership trends for Bain Capital Specialty Finance
.

Which institutional investors are selling Bain Capital Specialty Finance stock?

BCSF stock was sold by a variety of institutional investors in the last quarter, including Parallel Advisors LLC, First Republic Investment Management Inc., Virtus ETF Advisers LLC, Mission Wealth Management LP, Texas Yale Capital Corp., FCG Advisors LLC, One Charles Private Wealth Services LLC, and JNB Advisors LLC.
View insider buying and selling activity for Bain Capital Specialty Finance
.

Which institutional investors are buying Bain Capital Specialty Finance stock?

BCSF stock was bought by a variety of institutional investors in the last quarter, including UBS Group AG, Sumitomo Mitsui Trust Holdings Inc., Mckinley Capital Management LLC Delaware, Meridian Investment Counsel Inc., Mount Yale Investment Advisors LLC, C.V. Starr & Co. Inc. Trust, Starr International Co. Inc., and J.W. Cole Advisors Inc.. Company insiders that have bought Bain Capital Specialty Finance stock in the last two years include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle, and Thomas A Hough.
View insider buying and selling activity for Bain Capital Specialty Finance
.

How do I buy shares of Bain Capital Specialty Finance?

Shares of BCSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Bain Capital Specialty Finance's stock price today?

One share of BCSF stock can currently be purchased for approximately $10.91.

How big of a company is Bain Capital Specialty Finance?

Bain Capital Specialty Finance has a market capitalization of $704.37 million and generates $197.95 million in revenue each year. The company earns $98.08 million in net income (profit) each year or $1.64 on an earnings per share basis.

What is Bain Capital Specialty Finance's official website?

The official website for Bain Capital Specialty Finance is www.baincapital.com.

How can I contact Bain Capital Specialty Finance?

Bain Capital Specialty Finance's mailing address is 200 CLARENDON STREET 37TH FLOOR, BOSTON MA, 02116. The company can be reached via phone at 617-516-2000 or via email at [email protected]

This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.